rs76773579
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000811.3(GABRA6):āc.710A>Gā(p.Gln237Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00284 in 1,613,782 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_000811.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00227 AC: 345AN: 152192Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.00309 AC: 776AN: 251374Hom.: 3 AF XY: 0.00324 AC XY: 440AN XY: 135846
GnomAD4 exome AF: 0.00291 AC: 4246AN: 1461472Hom.: 10 Cov.: 31 AF XY: 0.00306 AC XY: 2226AN XY: 727046
GnomAD4 genome AF: 0.00227 AC: 345AN: 152310Hom.: 5 Cov.: 32 AF XY: 0.00215 AC XY: 160AN XY: 74474
ClinVar
Submissions by phenotype
Childhood absence epilepsy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 28, 2020 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
GABRA6-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 17, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at